Home › Funds › DAVIDSON INVESTMENT ADVISORS › CVS

DAVIDSON INVESTMENT ADVISORS position in CVS

CVS HEALTH CORP · Consumer Staples

DAVIDSON INVESTMENT ADVISORS reported holding 204,568 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$17.5M, representing 0.73% of its reported portfolio and ranking #47 among its reported holdings. DAVIDSON INVESTMENT ADVISORS has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)204.57K sh
Reported value held$17.53M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DAVIDSON INVESTMENT ADVISORS's CVS position evolved

DAVIDSON INVESTMENT ADVISORS first disclosed a stake in CVS in Q3 2023 at 221,848 shares (US$15.5M). The position peaked in Q2 2026 at 244,542 shares, worth US$25.3M. Across 13 filings, DAVIDSON INVESTMENT ADVISORS increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 204,568 shares valued at US$17.5M — a reduction of -39,974 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2024 (shares rose 53% over the following quarter), a 29% increase in Q2 2025 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 221.85K $15.49M New
Q4 2023 218.95K $17.29M Reduce
Q1 2024 218.95K $17.46M Hold
Q2 2024 213.93K $12.63M Reduce
Q3 2024 220.35K $13.86M Add
Q4 2024 161.37K $7.24M Reduce
Q1 2025 198.83K $13.47M Add
Q2 2025 256.57K $17.70M Add
Q3 2025 255.00K $19.22M Reduce
Q4 2025 250.94K $19.91M Reduce
Q1 2026 246.08K $17.67M Reduce
Q2 2026 244.54K $25.30M Reduce
Q3 2026 204.57K $17.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has DAVIDSON INVESTMENT ADVISORS held CVS?

DAVIDSON INVESTMENT ADVISORS has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DAVIDSON INVESTMENT ADVISORS's current position in CVS?

As of Q3 2026, DAVIDSON INVESTMENT ADVISORS holds 204.57K shares of CVS (CVS HEALTH CORP), valued at $17.53M, representing 0.73% of its reported portfolio and ranking #47.

Has DAVIDSON INVESTMENT ADVISORS been buying or selling CVS?

In the latest 13F filing (Q3 2026), DAVIDSON INVESTMENT ADVISORS reduced its position in CVS. The position peaked in Q2 2026 at 244.54K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.